I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...
Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...
It goes on to note that: Endocrinologists diagnose and treat a wide range of conditions affecting the endocrine system, including diabetes ... came in 2022. Presentation slide 10 describes its ...
Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billion. On the basis of U.S. generally ...
Annual Results/Quarter Results Strong 2024 performance reflects Straumann Group’s strengths in innovation and execution 19-Feb-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.
We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to ... causing disease in patients with multiple sclerosis, type 1 diabetes, and ...
Cynata Therapeutics Limited ( OTCPK:CYYNF) Investor Webinar Conference Call February 5, 2025 6:30 PM ET Lauren Nowak - Media Relations Kilian Kelly - Chief Executive Officer and Managing Director ...
Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., Feb. 13, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its ...
The Revere Board of Health held its first regular meeting of the new year on January 23 in the City Council Chambers. On hand for the session were the board’s three members, chairperson Dr. Drew ...
SAN DIEGO, February 13, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...